(WES) Western Midstream Partners - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US9586691035
Stock: Natural Gas, Crude Oil, Liquids, Water Handling
Total Rating 36
Risk 71
Buy Signal -0.81
| Risk 5d forecast | |
|---|---|
| Volatility | 22.4% |
| Relative Tail Risk | 0.16% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.31 |
| Alpha | -1.50 |
| Character TTM | |
|---|---|
| Beta | 0.509 |
| Beta Downside | 0.182 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.65% |
| CAGR/Max DD | 1.69 |
EPS (Earnings per Share)
Revenue
Description: WES Western Midstream Partners March 05, 2026
Western Midstream Partners, LP (WES) is a U.S. midstream energy company. Its operations include natural gas gathering, compression, treating, processing, and transportation. The company also handles condensate, natural gas liquids (NGLs), and crude oil, including gathering, stabilization, and transportation. Midstream companies typically act as a link between upstream production and downstream refining/processing.
WES engages in the buying and selling of residue, NGLs, and condensates. It also provides water handling solutions, a common service in oil and gas production. Its primary operational areas are Texas, New Mexico, and the Rocky Mountains. The company was founded in 2007 and is headquartered in The Woodlands, Texas. Further analysis on ValueRay can provide deeper insights into WESs operational metrics and financial performance.
Headlines to watch out for
- Crude oil and natural gas prices impact gathering and processing demand
- Regulatory changes to pipeline operations increase compliance costs
- Production volumes in Delaware Basin and DJ Basin drive throughput
- Interest rate fluctuations affect debt servicing costs
- Acquisition and divestiture activity alters asset portfolio and cash flow
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 1.17b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 0.14 > 1.0 |
| NWC/Revenue: 10.94% < 20% (prev 4.31%; Δ 6.63% < -1%) |
| CFO/TA 0.15 > 3% & CFO 2.22b > Net Income 1.17b |
| Net Debt (8.11b) to EBITDA (2.30b): 3.52 < 3 |
| Current Ratio: 1.34 > 1.5 & < 3 |
| Outstanding Shares: last quarter (402.5m) vs 12m ago 5.10% < -2% |
| Gross Margin: 68.46% > 18% (prev 0.77%; Δ 6.77k% > 0.5%) |
| Asset Turnover: 27.31% > 50% (prev 27.43%; Δ -0.11% > 0%) |
| Interest Coverage Ratio: 4.08 > 6 (EBITDA TTM 2.30b / Interest Expense TTM 390.5m) |
Altman Z''
| A: 0.03 (Total Current Assets 1.66b - Total Current Liabilities 1.24b) / Total Assets 15.00b |
| B: error (Retained Earnings missing) |
| C: 0.11 (EBIT TTM 1.59b / Avg Total Assets 14.07b) |
| D: 0.37 (Book Value of Equity 4.02b / Total Liabilities 10.84b) |
Beneish M -2.77
| DSRI: 1.03 (Receivables 788.8m/721.4m, Revenue 3.84b/3.61b) |
| GMI: 1.13 (GM 68.46% / 77.18%) |
| AQI: 1.24 (AQ_t 0.13 / AQ_t-1 0.10) |
| SGI: 1.07 (Revenue 3.84b / 3.61b) |
| TATA: -0.07 (NI 1.17b - CFO 2.22b) / TA 15.00b) |
| Beneish M-Score: -2.77 (Cap -4..+1) = A |
What is the price of WES shares?
As of March 18, 2026, the stock is trading at USD 41.46 with a total of 1,123,580 shares traded.
Over the past week, the price has changed by +3.42%, over one month by -5.19%, over three months by +8.17% and over the past year by +9.00%.
Over the past week, the price has changed by +3.42%, over one month by -5.19%, over three months by +8.17% and over the past year by +9.00%.
Is WES a buy, sell or hold?
Western Midstream Partners has received a consensus analysts rating of 3.15.
Therefor, it is recommend to hold WES.
- StrongBuy: 2
- Buy: 1
- Hold: 8
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the WES price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 41.8 | 0.9% |
| Analysts Target Price | 41.8 | 0.9% |
WES Fundamental Data Overview March 18, 2026
P/E Trailing = 13.7617
P/E Forward = 10.929
P/S = 4.3534
P/B = 4.0148
P/EG = 5.48
Revenue TTM = 3.84b USD
EBIT TTM = 1.59b USD
EBITDA TTM = 2.30b USD
Long Term Debt = 8.18b USD (from longTermDebt, last quarter)
Short Term Debt = 514.1m USD (from shortTermDebt, last quarter)
Debt = 8.93b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.11b USD (from netDebt column, last quarter)
Enterprise Value = 24.84b USD (16.73b + Debt 8.93b - CCE 819.5m)
Interest Coverage Ratio = 4.08 (Ebit TTM 1.59b / Interest Expense TTM 390.5m)
EV/FCF = 16.61x (Enterprise Value 24.84b / FCF TTM 1.50b)
FCF Yield = 6.02% (FCF TTM 1.50b / Enterprise Value 24.84b)
FCF Margin = 38.92% (FCF TTM 1.50b / Revenue TTM 3.84b)
Net Margin = 30.43% (Net Income TTM 1.17b / Revenue TTM 3.84b)
Gross Margin = 68.46% ((Revenue TTM 3.84b - Cost of Revenue TTM 1.21b) / Revenue TTM)
Gross Margin QoQ = 49.41% (prev 72.33%)
Tobins Q-Ratio = 1.66 (Enterprise Value 24.84b / Total Assets 15.00b)
Interest Expense / Debt = 1.25% (Interest Expense 111.9m / Debt 8.93b)
Taxrate = 3.60% (7.32m / 203.6m)
NOPAT = 1.54b (EBIT 1.59b * (1 - 3.60%))
Current Ratio = 1.34 (Total Current Assets 1.66b / Total Current Liabilities 1.24b)
Debt / Equity = 2.22 (Debt 8.93b / totalStockholderEquity, last quarter 4.02b)
Debt / EBITDA = 3.52 (Net Debt 8.11b / EBITDA 2.30b)
Debt / FCF = 5.42 (Net Debt 8.11b / FCF TTM 1.50b)
Total Stockholder Equity = 3.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.31% (Net Income 1.17b / Total Assets 15.00b)
RoE = 34.44% (Net Income TTM 1.17b / Total Stockholder Equity 3.40b)
RoCE = 13.75% (EBIT 1.59b / Capital Employed (Equity 3.40b + L.T.Debt 8.18b))
RoIC = 14.19% (NOPAT 1.54b / Invested Capital 10.82b)
WACC = 5.50% (E(16.73b)/V(25.66b) * Re(7.79%) + D(8.93b)/V(25.66b) * Rd(1.25%) * (1-Tc(0.04)))
Discount Rate = 7.79% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 2.76%
[DCF] Terminal Value 86.85% ; FCFF base≈1.41b ; Y1≈1.49b ; Y5≈1.76b
[DCF] Fair Price = 111.7 (EV 52.10b - Net Debt 8.11b = Equity 43.99b / Shares 393.7m; r=5.90% [WACC]; 5y FCF grow 5.99% → 2.90% )
EPS Correlation: 11.29 | EPS CAGR: -11.30% | SUE: -1.94 | # QB: 0
Revenue Correlation: 79.84 | Revenue CAGR: 8.55% | SUE: -1.33 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.83 | Chg7d=-0.002 | Chg30d=-0.074 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=3.37 | Chg7d=-0.016 | Chg30d=-0.282 | Revisions Net=-3 | Growth EPS=+10.8% | Growth Revenue=+8.2%
EPS next Year (2027-12-31): EPS=3.87 | Chg7d=-0.099 | Chg30d=-0.092 | Revisions Net=+1 | Growth EPS=+14.8% | Growth Revenue=+6.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.7% (Discount Rate 7.9% - Earnings Yield 7.3%)
[Growth] Growth Spread = +11.9% (Analyst 12.5% - Implied 0.7%)
P/E Forward = 10.929
P/S = 4.3534
P/B = 4.0148
P/EG = 5.48
Revenue TTM = 3.84b USD
EBIT TTM = 1.59b USD
EBITDA TTM = 2.30b USD
Long Term Debt = 8.18b USD (from longTermDebt, last quarter)
Short Term Debt = 514.1m USD (from shortTermDebt, last quarter)
Debt = 8.93b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.11b USD (from netDebt column, last quarter)
Enterprise Value = 24.84b USD (16.73b + Debt 8.93b - CCE 819.5m)
Interest Coverage Ratio = 4.08 (Ebit TTM 1.59b / Interest Expense TTM 390.5m)
EV/FCF = 16.61x (Enterprise Value 24.84b / FCF TTM 1.50b)
FCF Yield = 6.02% (FCF TTM 1.50b / Enterprise Value 24.84b)
FCF Margin = 38.92% (FCF TTM 1.50b / Revenue TTM 3.84b)
Net Margin = 30.43% (Net Income TTM 1.17b / Revenue TTM 3.84b)
Gross Margin = 68.46% ((Revenue TTM 3.84b - Cost of Revenue TTM 1.21b) / Revenue TTM)
Gross Margin QoQ = 49.41% (prev 72.33%)
Tobins Q-Ratio = 1.66 (Enterprise Value 24.84b / Total Assets 15.00b)
Interest Expense / Debt = 1.25% (Interest Expense 111.9m / Debt 8.93b)
Taxrate = 3.60% (7.32m / 203.6m)
NOPAT = 1.54b (EBIT 1.59b * (1 - 3.60%))
Current Ratio = 1.34 (Total Current Assets 1.66b / Total Current Liabilities 1.24b)
Debt / Equity = 2.22 (Debt 8.93b / totalStockholderEquity, last quarter 4.02b)
Debt / EBITDA = 3.52 (Net Debt 8.11b / EBITDA 2.30b)
Debt / FCF = 5.42 (Net Debt 8.11b / FCF TTM 1.50b)
Total Stockholder Equity = 3.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.31% (Net Income 1.17b / Total Assets 15.00b)
RoE = 34.44% (Net Income TTM 1.17b / Total Stockholder Equity 3.40b)
RoCE = 13.75% (EBIT 1.59b / Capital Employed (Equity 3.40b + L.T.Debt 8.18b))
RoIC = 14.19% (NOPAT 1.54b / Invested Capital 10.82b)
WACC = 5.50% (E(16.73b)/V(25.66b) * Re(7.79%) + D(8.93b)/V(25.66b) * Rd(1.25%) * (1-Tc(0.04)))
Discount Rate = 7.79% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 2.76%
[DCF] Terminal Value 86.85% ; FCFF base≈1.41b ; Y1≈1.49b ; Y5≈1.76b
[DCF] Fair Price = 111.7 (EV 52.10b - Net Debt 8.11b = Equity 43.99b / Shares 393.7m; r=5.90% [WACC]; 5y FCF grow 5.99% → 2.90% )
EPS Correlation: 11.29 | EPS CAGR: -11.30% | SUE: -1.94 | # QB: 0
Revenue Correlation: 79.84 | Revenue CAGR: 8.55% | SUE: -1.33 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.83 | Chg7d=-0.002 | Chg30d=-0.074 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=3.37 | Chg7d=-0.016 | Chg30d=-0.282 | Revisions Net=-3 | Growth EPS=+10.8% | Growth Revenue=+8.2%
EPS next Year (2027-12-31): EPS=3.87 | Chg7d=-0.099 | Chg30d=-0.092 | Revisions Net=+1 | Growth EPS=+14.8% | Growth Revenue=+6.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.7% (Discount Rate 7.9% - Earnings Yield 7.3%)
[Growth] Growth Spread = +11.9% (Analyst 12.5% - Implied 0.7%)